Zealand Pharma — Director's Dealing 2021

Feb 8, 2021

FINANSTILSYNET

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Matthew Donald Dallas
2.	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI	549300ITBB1ULBL4CZ12
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument
Identification code	Shares
DK0060257814
b)	Nature of the transaction	Subscription of shares
c)	Price(s) and volume(s)	Price(s) Volume(s)
		DKK 208 841
d)	Aggregated information
- Aggregated volume
- Price	DKK 174,928
e)	Date of the transaction	27 January 2021
f)	Place of the transaction	Outside market place

Updated 5 March 2018